(Q54106220)

English

Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Massimo Zucchetti

4

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

Maurizio D'Incalci

11

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

author name string

C Sessa

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

C Minoia

2

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

A Ronchi

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

J Bauer

5

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

M Borner

6

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

J de Jong

7

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

O Pagani

8

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

J Renard

9

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

C Weil

10

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

publication date

1 December 1998

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

9

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

12

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

1315-1322

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008441416790

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008441416790

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008441416790

7 January 2021

based on heuristic

inferred from DOI database lookup

NL-FIT: a microcomputer program for non-linear fitting.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008441416790

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotransformation of the platinum drug JM216 following oral administration to cancer patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008441416790

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008441416790

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy involving orally administered etoposide and JM-216 in murine tumor models

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008441416790

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008441416790

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/9932162

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54106220&oldid=2143354016"